Literature DB >> 23264324

General pathophysiology of macular edema.

Stefan Scholl1, Albert Augustin, Anat Loewenstein, Stanislao Rizzo, Baruch Kupperman.   

Abstract

Macular edema represents a common final pathway for many ocular diseases. Related ocular disorders include diabetic retinopathy, vascular occlusions, postsurgical situations, and uveitic diseases. The key pathophysiologic process is a breakdown of the blood-retinal barrier, normally preventing water movement in the retina, thus allowing fluid to accumulate in the retinal tissue via special water fluxes. Inflammatory processes and an increase in vascular permeability play a central role. Different mechanisms, complicated by ischemic conditions, interact in a complex network. Key factors are angiotensin II, prostaglandins, and the vascular endothelial growth factor. The various pathogenetic mechanisms and their contribution to the edema process are described in detail in this article.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 23264324     DOI: 10.5301/EJO.2010.6050

Source DB:  PubMed          Journal:  Eur J Ophthalmol        ISSN: 1120-6721            Impact factor:   2.597


  21 in total

1.  Macular oedema in Kawasaki syndrome.

Authors:  Justus G Garweg; Claudia Suter; Christine Aebi-Ochsner; Reto Villiger
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2012-01-06       Impact factor: 3.117

2.  Treatment and functional outcome of patients with cystoid macular edema: a single-center experience.

Authors:  Mara Taraborelli; Ilaria Cavazzana; Micaela Fredi; Paolo Airò; Giuseppe Nascimbeni; Angela Tincani; Franco Franceschini
Journal:  Clin Rheumatol       Date:  2014-06-11       Impact factor: 2.980

3.  Ischemia-reperfusion injury induces occludin phosphorylation/ubiquitination and retinal vascular permeability in a VEGFR-2-dependent manner.

Authors:  Arivalagan Muthusamy; Cheng-Mao Lin; Sumathi Shanmugam; Heather M Lindner; Steven F Abcouwer; David A Antonetti
Journal:  J Cereb Blood Flow Metab       Date:  2014-01-08       Impact factor: 6.200

4.  Hypoxic retinal Muller cells promote vascular permeability by HIF-1-dependent up-regulation of angiopoietin-like 4.

Authors:  Xiaoban Xin; Murilo Rodrigues; Mahaa Umapathi; Fabiana Kashiwabuchi; Tao Ma; Savalan Babapoor-Farrokhran; Shuang Wang; Jiadi Hu; Imran Bhutto; Derek S Welsbie; Elia J Duh; James T Handa; Charles G Eberhart; Gerard Lutty; Gregg L Semenza; Silvia Montaner; Akrit Sodhi
Journal:  Proc Natl Acad Sci U S A       Date:  2013-08-19       Impact factor: 11.205

Review 5.  The therapeutic potential of intraocular depot steroid systems: developments aimed at prolonging duration of efficacy.

Authors:  Martin M Nentwich; Michael W Ulbig
Journal:  Dtsch Arztebl Int       Date:  2012-09-14       Impact factor: 5.594

6.  Potential role of Cyr61 induced degeneration of human Müller cells in diabetic retinopathy.

Authors:  Fen Zhou; Yikui Zhang; Ding Chen; Zhitao Su; Ling Jin; Lei Wang; Zhixiang Hu; Zhisheng Ke; Zongming Song
Journal:  PLoS One       Date:  2014-10-16       Impact factor: 3.240

7.  Comparison of Cysts in Red and Green Images for Diabetic Macular Edema.

Authors:  Mastour A Alhamami; Ann E Elsner; Victor E Malinovsky; Christopher A Clark; Bryan P Haggerty; Glen Y Ozawa; Jorge A Cuadros; Karthikeyan Baskaran; Thomas J Gast; Taras V Litvin; Matthew S Muller; Shane G Brahm; Stuart B Young; Masahiro Miura
Journal:  Optom Vis Sci       Date:  2017-02       Impact factor: 1.973

8.  The effect of oral acetazolamide on cystoid macular edema in hydroxychloroquine retinopathy: a case report.

Authors:  Eun Hee Hong; Seong Joon Ahn; Han Woong Lim; Byung Ro Lee
Journal:  BMC Ophthalmol       Date:  2017-07-12       Impact factor: 2.209

Review 9.  Dexamethasone intravitreal implant in the treatment of diabetic macular edema.

Authors:  Pravin U Dugel; Francesco Bandello; Anat Loewenstein
Journal:  Clin Ophthalmol       Date:  2015-07-16

10.  Retrospective analyses of optical coherence tomography in recurrent macular edema following intravitreal therapy in patients with retinal vein occlusion.

Authors:  Stephen M Holland; David G Dodwell; Darrel A Krimmel; Christopher M de Fiebre
Journal:  BMC Ophthalmol       Date:  2015-09-04       Impact factor: 2.209

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.